Sacubitril/valsartan: research progress of multi-channel therapy for cardiorenal syndrome
Cardiorenal syndrome (CRS) results from complex interaction between heart and kidneys, inducing simultaneous acute or chronic dysfunction of these organs. Although its incidence rate is increasing with higher mortality in patients, effective clinical treatment drugs are currently not available. The...
Saved in:
Main Authors: | Shuangcui Wang (Author), Yuli Wang (Author), Yun Deng (Author), Jiaqi Zhang (Author), Xijuan Jiang (Author), Jianchun Yu (Author), Jiali Gan (Author), Wenyun Zeng (Author), Maojuan Guo (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2023-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Molecular mechanisms of sacubitril/valsartan in cardiac remodeling
by: Nor Hidayah Mustafa, et al.
Published: (2022) -
Sacubitril/valsartan in real-life clinical practice
by: Yüksel Çavuşoğlu
Published: (2021) -
Sacubitril/valsartan: evaluation of safety and efficacy as an antihypertensive treatment
by: Sarah L Anderson, et al.
Published: (2018) -
The concentration of maternal sacubitril/valsartan transferred into human milk is negligible
by: Sirin Falconi, et al.
Published: (2024) -
Pathogenetic justification of sacubitril / valsartan use in respiratory-cardial comorbidity
by: T. V. Ashcheulova, et al.
Published: (2023)